Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using Solriamfetol

Clinical trial NCT06360419 · COMPLETED

Trial details

NCT number: NCT06360419
Sponsor: Axsome Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2024-03-18
Primary completion: 2024-12-31
Enrollment: 346

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.